Hosted on MSN6h
Stifel Downgrades IGM Biosciences (IGMS)Fintel reports that on January 10, 2025, Stifel downgraded their outlook for IGM Biosciences (NasdaqGS:IGMS) from Buy to Hold ...
Hosted on MSN6h
Jefferies Downgrades IGM Biosciences (IGMS)Fintel reports that on January 10, 2025, Jefferies downgraded their outlook for IGM Biosciences (NasdaqGS:IGMS) from Buy to ...
The biotech will stop developing two drugs and lay off nearly three-quarters of its staff after its lead therapy wasn’t as ...
1don MSN
IGM Biosciences Inc. said Thursday it is cutting 73% of its workforce after deciding to halt further development of a program relating to its autoimmunity-drug pipeline, sending its stock down 69% in ...
Shares of IGM Biosciences, Inc. (NASDAQ:IGMS – Get Free Report) have been given a consensus rating of “Moderate Buy” by the eight research firms that are currently covering the stock, Marketbeat ...
High serum CXCL13 levels are predictive of treatment failure with first-line MTX among patients with early RA.
eMBR Genomics Partners with Axio BioPharma to Make MKLP1 ProTM Antibodies Commercially Available ...
MBR Genomics partners with Axio BioPharma to make MKLP1 Pro antibodies commercially available: Madison, Wisconsin Tuesday, January 7, 2025, 15:00 Hrs [IST] In a milestone for cel ...
The COVID-19 pandemic revealed the devastating impact of global diseases. As the world recovers, experts warn of new and re-emerging threats like HMPV, measles, dengue, bird flu, and more. With over ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback